Published in
Elsevier, Cancer Letters, (414), p. 99-106
DOI: 10.1016/j.canlet.2017.09.053
Links
Tools
Mutant p53 as a therapeutic target for the treatment of triple-negative breast cancer: Preclinical investigation with the anti-p53 drug, PK11007
Journal article published in 2018 by
Naoise C. Synnott,
Matthias R. Bauer 
,
Stephen Madden,
Alyson Murray,
Rut Klinger,
Norma O'Donovan,
Darran O'Connor ,
William M. Gallagher,
John Crown,
Alan R. Fersht,
Michael J. Duffy
,
Stephen Madden,
Alyson Murray,
Rut Klinger,
Norma O'Donovan,
Darran O'Connor ,
William M. Gallagher,
John Crown,
Alan R. Fersht,
Michael J. Duffy
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 